123 related articles for article (PubMed ID: 37721612)
1. Piperacillin-Tazobactam vs Cefoxitin Prophylaxis for Pancreatoduodenectomy-Reply.
Ellis RJ; Ko CY; D'Angelica MI
JAMA; 2023 Sep; 330(11):1099-1100. PubMed ID: 37721612
[No Abstract] [Full Text] [Related]
2. Piperacillin-Tazobactam vs Cefoxitin Prophylaxis for Pancreatoduodenectomy.
Sawyer RG
JAMA; 2023 Sep; 330(11):1098-1099. PubMed ID: 37721617
[No Abstract] [Full Text] [Related]
3. Piperacillin-Tazobactam vs Cefoxitin Prophylaxis for Pancreatoduodenectomy.
Yang Z; Mei J; Gong W
JAMA; 2023 Sep; 330(11):1098. PubMed ID: 37721616
[No Abstract] [Full Text] [Related]
4. Piperacillin-Tazobactam vs Cefoxitin Prophylaxis for Pancreatoduodenectomy.
Jouffroy R; Lupinacci RM; Dournon N
JAMA; 2023 Sep; 330(11):1097-1098. PubMed ID: 37721615
[No Abstract] [Full Text] [Related]
5. Association Between Biliary Pathogens, Surgical Site Infection, and Pancreatic Fistula: Results of a Randomized Trial of Perioperative Antibiotic Prophylaxis in Patients Undergoing Pancreatoduodenectomy.
Ellis RJ; Brajcich BC; Bertens KA; Chan CHF; Castillo CF; Karanicolas PJ; Maithel SK; Reames BN; Weber SM; Vidri RJ; Pitt HA; Thompson VM; Gonen M; Seo SK; Yopp AC; Ko CY; D'Angelica MI
Ann Surg; 2023 Sep; 278(3):310-319. PubMed ID: 37314221
[TBL] [Abstract][Full Text] [Related]
6. Piperacillin-Tazobactam Compared With Cefoxitin as Antimicrobial Prophylaxis for Pancreatoduodenectomy: A Randomized Clinical Trial.
D'Angelica MI; Ellis RJ; Liu JB; Brajcich BC; Gönen M; Thompson VM; Cohen ME; Seo SK; Zabor EC; Babicky ML; Bentrem DJ; Behrman SW; Bertens KA; Celinski SA; Chan CHF; Dillhoff M; Dixon MEB; Fernandez-Del Castillo C; Gholami S; House MG; Karanicolas PJ; Lavu H; Maithel SK; McAuliffe JC; Ott MJ; Reames BN; Sanford DE; Sarpel U; Scaife CL; Serrano PE; Smith T; Snyder RA; Talamonti MS; Weber SM; Yopp AC; Pitt HA; Ko CY
JAMA; 2023 May; 329(18):1579-1588. PubMed ID: 37078771
[TBL] [Abstract][Full Text] [Related]
7. Cefoxitin versus piperacillin-tazobactam as surgical antibiotic prophylaxis in patients undergoing pancreatoduodenectomy: protocol for a randomised controlled trial.
Nevarez NM; Brajcich BC; Liu J; Ellis R; Ko CY; Pitt HA; D'Angelica MI; Yopp AC
BMJ Open; 2021 Mar; 11(3):e048398. PubMed ID: 33664081
[TBL] [Abstract][Full Text] [Related]
8. Antibiotic Prophylaxis with Piperacillin-Tazobactam Reduces Post-Operative Infectious Complication after Pancreatic Surgery: An Interventional, Non-Randomized Study.
De Pastena M; Paiella S; Azzini AM; Zaffagnini A; Scarlini L; Montagnini G; Maruccio M; Filippini C; Romeo F; Mazzariol A; Cascio GL; Bazaj A; Secchettin E; Bassi C; Salvia R
Surg Infect (Larchmt); 2021 Jun; 22(5):536-542. PubMed ID: 33095107
[No Abstract] [Full Text] [Related]
9. A NSQIP-based randomized clinical trial evaluating choice of prophylactic antibiotics for pancreaticoduodenectomy.
Brajcich BC; Ko CY; Liu JB; Ellis RJ; D Angelica MI
J Surg Oncol; 2021 May; 123(6):1387-1394. PubMed ID: 33831250
[TBL] [Abstract][Full Text] [Related]
10. Antibiotic prophylaxis with piperacillin-tazobactam reduces organ/space surgical site infection after pancreaticoduodenectomy: a retrospective and propensity score-matched analysis.
Yang Y; Sheng J; Cai Z; Zhu L; Lu C; Mao L; Qiu Y; Fu X
BMC Cancer; 2024 Feb; 24(1):251. PubMed ID: 38395787
[TBL] [Abstract][Full Text] [Related]
11. Piperacillin/Tazobactam versus Tobramycin-Based Antibiotic Prophylaxis for Type III Open Fractures.
Shawar SK; Ly TV; Li J; Shirk MB; Reichert EM
Surg Infect (Larchmt); 2020 Feb; 21(1):23-28. PubMed ID: 31381489
[No Abstract] [Full Text] [Related]
12. Piperacillin/tazobactam versus cefepime or carbapenems for cefoxitin-non-susceptible Enterobacter cloacae, Klebsiella aerogenes, Citrobacter freundii, Serratia marcescens and Morganella morganii bacteraemia in immunocompromised patients.
Lu B; Wong M; Ha D; Bounthavong M; Banaei N; Deresinski S; Diep C
J Antimicrob Chemother; 2023 Apr; 78(4):1009-1014. PubMed ID: 36879495
[TBL] [Abstract][Full Text] [Related]
13. Antimicrobial prophylaxis for transurethral resection of bladder tumor: A retrospective comparison of preoperative single-dose administration of piperacillin and tazobactam/piperacillin.
Murakami M; Kiyota H; Kasai K; Bando S; Kira S; Koide H; Yamada H; Kimura T; Egawa S
J Infect Chemother; 2018 Dec; 24(12):954-957. PubMed ID: 30193786
[TBL] [Abstract][Full Text] [Related]
14. Perioperative antibiotherapy should replace prophylactic antibiotics in patients undergoing pancreaticoduodenectomy preceded by preoperative biliary drainage.
Degrandi O; Buscail E; Martellotto S; Gronnier C; Collet D; Adam JP; Ouattara A; Laurent C; Dewitte A; Chiche L
J Surg Oncol; 2019 Sep; 120(4):639-645. PubMed ID: 31297827
[TBL] [Abstract][Full Text] [Related]
15. Perioperative antibiotics for surgical site infection in pancreaticoduodenectomy: does the SCIP-approved regimen provide adequate coverage?
Donald GW; Sunjaya D; Lu X; Chen F; Clerkin B; Eibl G; Li G; Tomlinson JS; Donahue TR; Reber HA; Hines OJ
Surgery; 2013 Aug; 154(2):190-6. PubMed ID: 23664266
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of Piperacillin-Tazobactam for Antibiotic Prophylaxis in Traumatic Grade III Open Fractures.
O'Connell CR; Kooda KJ; Sawyer MD; Wise KB; Mara KC; Skrupky LP
Surg Infect (Larchmt); 2022 Feb; 23(1):41-46. PubMed ID: 34612703
[No Abstract] [Full Text] [Related]
17. Cefepime vs Piperacillin-Tazobactam for Acute Infection in Hospitalized Adults-Reply.
Qian ET; Semler MW; Rice TW
JAMA; 2024 Feb; 331(8):709-710. PubMed ID: 38411646
[No Abstract] [Full Text] [Related]
18. Piperacillin/tazobactam vs carbapenems for patients with bacterial infection: Protocol for a systematic review.
Petersen MW; Perner A; Sjövall F; Jonsson AB; Steensen M; Andersen JS; Achiam MP; Frimodt-Møller N; Møller MH
Acta Anaesthesiol Scand; 2019 Aug; 63(7):973-978. PubMed ID: 31020663
[TBL] [Abstract][Full Text] [Related]
19. Results of the effectiveness of two piperacillin-tazobactam molecules in the real world.
Machado-Alba JE; Gaviria-Mendoza A; Machado-Duque ME
Int J Infect Dis; 2018 Nov; 76():91-96. PubMed ID: 30244077
[TBL] [Abstract][Full Text] [Related]
20. Concerns about study design and suggestion of additional analysis of therapeutic drug monitoring-guided piperacillin/tazobactam therapy for patients with sepsis. Author's reply.
Hagel S; Pletz MW; Lehmann T
Intensive Care Med; 2022 Jun; 48(6):772-773. PubMed ID: 35292826
[No Abstract] [Full Text] [Related]
[Next] [New Search]
